Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 3/2020

02.03.2020 | Gynecologic Oncology

Fertility preservation treatment of gynecological cancer patients in Spain: a national survey (GOFER study)

verfasst von: Mikel Gorostidi, Blanca Gil-Ibañez, Sonsoles Alonso, Antonio Gil-Moreno, Alicia Hernandez, Aureli Torné, Ignacio Zapardiel

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To analyze the current management and use of fertility preservation (FP) treatments among different gynecologic oncology centers in Spain

Methods

From March to April 2019, a transversal study was conducted using a national online survey to consultants registered in the section of Gynecologic Oncology of the Spanish Society of Obstetrics and Gynecology. The survey contained 30 questions that assessed the perceptions and attitudes towards fertility-sparing strategies as well as its management in each participating center.

Results

A total of 51 responders from 12 out of 17 geographical regions of Spain answered the survey. According to 35 responders (68.63%), the age limit for offering FP was 40 years. In most of the centers, an ovarian reserve study is carried out prior to a FP procedure (34 responders, 66.67%). In cervical cancer size, limit for offering trachelectomy is 2 cm (40 responders, 78.43%), with LVSI as an exclusion factor for 26 (51%). Twenty-four (48.98%) responders reported that FP only in ovarian cancer stages IA, 12 (24.49%) also in stages IB, and an additional 13 (26.53%) up to stages IC. Most responders perform FP only in the absence of myometrial infiltration (30, 58.82%) in patients with g1–g2 endometrial cancer.

Conclusions

The performance of professionals at the national level is uneven, demonstrating the need for referral centers to ensure optimal management. International guidelines should be more widely extended throughout Spain to homogenize the treatment of young oncology patients who wish to have children.
Literatur
1.
Zurück zum Zitat Ayhan A, Reed N, Gultekin M, Dursun P (eds) (2017) Textbook of gynaecological oncology, 4th edn. ESGO (European Society of Gynaecological Oncology). Ayhan A, Reed N, Gultekin M, Dursun P (eds) (2017) Textbook of gynaecological oncology, 4th edn. ESGO (European Society of Gynaecological Oncology).
3.
Zurück zum Zitat Bentivegna E, Gouy S, Maulard A, Chargari C, Leary A, Morice P (2016) Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. Lancet Oncol 17(6):e240–e253CrossRefPubMed Bentivegna E, Gouy S, Maulard A, Chargari C, Leary A, Morice P (2016) Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. Lancet Oncol 17(6):e240–e253CrossRefPubMed
4.
Zurück zum Zitat Zapardiel I, Diestro MD, Aletti G (2014) Conservative treatment of early stage ovarian cancer: oncological and fertility outcomes. Eur J Surg Oncol 40(4):387–393CrossRefPubMed Zapardiel I, Diestro MD, Aletti G (2014) Conservative treatment of early stage ovarian cancer: oncological and fertility outcomes. Eur J Surg Oncol 40(4):387–393CrossRefPubMed
5.
Zurück zum Zitat Simpson AN, Feigenberg T, Clarke BA, Gien LT, Ismiil N, Laframboise S et al (2014) Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin. Gynecol Oncol 133(2):229–233CrossRefPubMed Simpson AN, Feigenberg T, Clarke BA, Gien LT, Ismiil N, Laframboise S et al (2014) Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin. Gynecol Oncol 133(2):229–233CrossRefPubMed
6.
Zurück zum Zitat Robova H, Halaska MJ, Pluta M, Skapa P, Matecha J, Lisy J et al (2014) Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer. Gynecol Oncol 135(2):213–216CrossRefPubMed Robova H, Halaska MJ, Pluta M, Skapa P, Matecha J, Lisy J et al (2014) Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer. Gynecol Oncol 135(2):213–216CrossRefPubMed
8.
Zurück zum Zitat Oncoguía SEGO (2018) Cáncer de cuello uterino. Guías de práctica clínica en cáncer ginecológico y mamario. Publicaciones SEGO Oncoguía SEGO (2018) Cáncer de cuello uterino. Guías de práctica clínica en cáncer ginecológico y mamario. Publicaciones SEGO
9.
Zurück zum Zitat Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C et al (2018) The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Int J Gynecol Cancer 28(4):641–655CrossRefPubMed Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C et al (2018) The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Int J Gynecol Cancer 28(4):641–655CrossRefPubMed
10.
Zurück zum Zitat Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R et al (2018) Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med 379(20):1895–1904CrossRefPubMed Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R et al (2018) Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med 379(20):1895–1904CrossRefPubMed
11.
Zurück zum Zitat Willows K, Lennox G, Covens A (2016) Fertility-sparing management in cervical cancer: balancing oncologic outcomes with reproductive success. Gynecol Oncol Res Pract 3(1):9CrossRefPubMedPubMedCentral Willows K, Lennox G, Covens A (2016) Fertility-sparing management in cervical cancer: balancing oncologic outcomes with reproductive success. Gynecol Oncol Res Pract 3(1):9CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Helpman L, Grisaru D, Covens A (2011) Early adenocarcinoma of the cervix: Is radical vaginal trachelectomy safe? Gynecol Oncol 123(1):95–98CrossRefPubMed Helpman L, Grisaru D, Covens A (2011) Early adenocarcinoma of the cervix: Is radical vaginal trachelectomy safe? Gynecol Oncol 123(1):95–98CrossRefPubMed
13.
Zurück zum Zitat Zusterzeel PLM, Pol FJM, van Ham M, Zweemer RP, Bekkers RLM, Massuger LFAG et al (2016) Vaginal radical trachelectomy for early-stage cervical cancer: increased recurrence risk for adenocarcinoma. Int J Gynecol Cancer 26(7):1293–1299CrossRefPubMed Zusterzeel PLM, Pol FJM, van Ham M, Zweemer RP, Bekkers RLM, Massuger LFAG et al (2016) Vaginal radical trachelectomy for early-stage cervical cancer: increased recurrence risk for adenocarcinoma. Int J Gynecol Cancer 26(7):1293–1299CrossRefPubMed
14.
Zurück zum Zitat Agarwal S, Schmeler KM, Ramirez PT, Sun CC, Nick A, Dos Reis R et al (2011) Outcomes of patients undergoing radical hysterectomy for cervical cancer of high-risk histological subtypes. Int J Gynecol Cancer 21(1):123–127CrossRefPubMedPubMedCentral Agarwal S, Schmeler KM, Ramirez PT, Sun CC, Nick A, Dos Reis R et al (2011) Outcomes of patients undergoing radical hysterectomy for cervical cancer of high-risk histological subtypes. Int J Gynecol Cancer 21(1):123–127CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Ditto A, Martinelli F, Lorusso D, Haeusler E, Carcangiu M, Raspagliesi F (2014) Fertility sparing surgery in early stage epithelial ovarian cancer. J Gynecol Oncol 25(4):320CrossRefPubMedPubMedCentral Ditto A, Martinelli F, Lorusso D, Haeusler E, Carcangiu M, Raspagliesi F (2014) Fertility sparing surgery in early stage epithelial ovarian cancer. J Gynecol Oncol 25(4):320CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Thomakos N, Malakasis A, Machairiotis N, Zarogoulidis P, Rodolakis A (2018) Fertility sparing management in non-epithelial ovarian cancer. Which patients, what procedure and what outcome? J Cancer 9(24):4659–4664CrossRefPubMedPubMedCentral Thomakos N, Malakasis A, Machairiotis N, Zarogoulidis P, Rodolakis A (2018) Fertility sparing management in non-epithelial ovarian cancer. Which patients, what procedure and what outcome? J Cancer 9(24):4659–4664CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Gershenson DM (2017) Management of borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol 41:49–59CrossRefPubMed Gershenson DM (2017) Management of borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol 41:49–59CrossRefPubMed
18.
Zurück zum Zitat Bentivegna E, Gouy S, Maulard A, Pautier P, Leary A, Colombo N et al (2016) Fertility-sparing surgery in epithelial ovarian cancer: a systematic review of oncological issues. Ann Oncol 27(11):1994–2004CrossRefPubMed Bentivegna E, Gouy S, Maulard A, Pautier P, Leary A, Colombo N et al (2016) Fertility-sparing surgery in epithelial ovarian cancer: a systematic review of oncological issues. Ann Oncol 27(11):1994–2004CrossRefPubMed
19.
Zurück zum Zitat Uzan C, Courbiere B, Chabbert-Buffet N (2019) Tumeurs épithéliales de l’ovaire : préservation de la fertilité. Article rédigé sur la base de la recommandation nationale de bonnes pratiques cliniques en cancérologie intitulée « Conduites à tenir initiales devant des patientes atteintes d’un cancer épithélial de l’ovaire » élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY sous l’égide du CNGOF et labellisée par l’INCa. Gynécol Obs Fertil Sénol 47(2):180–186CrossRef Uzan C, Courbiere B, Chabbert-Buffet N (2019) Tumeurs épithéliales de l’ovaire : préservation de la fertilité. Article rédigé sur la base de la recommandation nationale de bonnes pratiques cliniques en cancérologie intitulée « Conduites à tenir initiales devant des patientes atteintes d’un cancer épithélial de l’ovaire » élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY sous l’égide du CNGOF et labellisée par l’INCa. Gynécol Obs Fertil Sénol 47(2):180–186CrossRef
20.
Zurück zum Zitat Kajiyama H, Shibata K, Mizuno M, Hosono S, Kawai M, Nagasaka T et al (2011) Fertility-sparing surgery in patients with clear-cell carcinoma of the ovary: is it possible? Hum Reprod 26(12):3297–3302CrossRefPubMed Kajiyama H, Shibata K, Mizuno M, Hosono S, Kawai M, Nagasaka T et al (2011) Fertility-sparing surgery in patients with clear-cell carcinoma of the ovary: is it possible? Hum Reprod 26(12):3297–3302CrossRefPubMed
21.
Zurück zum Zitat Park J-Y, Suh D-S, Kim J-H, Kim Y-M, Kim Y-T, Nam J-H (2016) Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary. Int J Gynaecol Obstet 134(1):49–52CrossRefPubMed Park J-Y, Suh D-S, Kim J-H, Kim Y-M, Kim Y-T, Nam J-H (2016) Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary. Int J Gynaecol Obstet 134(1):49–52CrossRefPubMed
22.
Zurück zum Zitat Chiva L, Lapuente F, González-Cortijo L, Carballo N, García JF, Rojo A et al (2008) Sparing fertility in young patients with endometrial cancer. Gynecol Oncol 111(2):S101–S104CrossRefPubMed Chiva L, Lapuente F, González-Cortijo L, Carballo N, García JF, Rojo A et al (2008) Sparing fertility in young patients with endometrial cancer. Gynecol Oncol 111(2):S101–S104CrossRefPubMed
23.
Zurück zum Zitat Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J et al (2016) ESMO-ESGO-ESTRO consensus conference on endometrial cancer. Int J Gynecol Cancer 26(1):2–30CrossRefPubMed Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J et al (2016) ESMO-ESGO-ESTRO consensus conference on endometrial cancer. Int J Gynecol Cancer 26(1):2–30CrossRefPubMed
24.
Zurück zum Zitat Koskas M, Uzan J, Luton D, Rouzier R, Daraï E (2014) Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis. Fertil Steril 101(3):785.e3–794.e3CrossRef Koskas M, Uzan J, Luton D, Rouzier R, Daraï E (2014) Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis. Fertil Steril 101(3):785.e3–794.e3CrossRef
25.
Zurück zum Zitat Kesic V, Rodolakis A, Denschlag D, Schneider A, Morice P, Amant F et al (2010) Fertility preserving management in gynecologic cancer patients: the need for centralization. Int J Gynecol Cancer 20(9):1613–1619PubMed Kesic V, Rodolakis A, Denschlag D, Schneider A, Morice P, Amant F et al (2010) Fertility preserving management in gynecologic cancer patients: the need for centralization. Int J Gynecol Cancer 20(9):1613–1619PubMed
Metadaten
Titel
Fertility preservation treatment of gynecological cancer patients in Spain: a national survey (GOFER study)
verfasst von
Mikel Gorostidi
Blanca Gil-Ibañez
Sonsoles Alonso
Antonio Gil-Moreno
Alicia Hernandez
Aureli Torné
Ignacio Zapardiel
Publikationsdatum
02.03.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2020
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-020-05468-8

Weitere Artikel der Ausgabe 3/2020

Archives of Gynecology and Obstetrics 3/2020 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.